
==== Front
J Health Popul Nutr
J Health Popul Nutr
Journal of Health, Population, and Nutrition
1606-0997
2072-1315
BioMed Central London

39227884
627
10.1186/s41043-024-00627-y
Research
Endocrine disrupting chemicals and obesity prevention: scoping review
Amon Mojca mojca.amon@kclj.si

Kek Tina
Klun Irma Virant
https://ror.org/01nr6fy72 grid.29524.38 0000 0004 0571 7705 Clinical Research Centre, University Medical Centre Ljubljana, Zaloška Cesta 2, 1000 Ljubljana, Slovenia
3 9 2024
3 9 2024
2024
43 1383 4 2024
17 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
Introduction

Exposure to endocrine disrupting chemicals (EDCs) can result in alterations of natural hormones in the body. The aim of this review article is to highlight the knowledge about EDCs and obesity.

Methods

A scoping review of the electronic literature was performed using PubMed platform for studies on EDCs and obesity published between the years 2013–2023. A total of 10 systematic reviews and meta-analysis studies met our inclusion criteria on more prominent EDCs focusing mainly on bisphenols, including parabens, triclosan, and phthalates, and their association with obesity.

Design

Scoping review.

Results

EDCs, mostly bisphenols and phthalates, are related to health effects, while there is less information on the impact of parabens and triclosan. A series of negative physiological effects involving obesogenic, diabetogenic, carcinogenic, and inflammatory mechanisms as well as epigenetic and microbiota modulations was related to a prolonged EDCs exposure. A more profound research of particular pollutants is required to illuminate the accelerating effects of particular EDCs, mixtures or their metabolites on the mechanism of the development of obesity.

Conclusion

Considering the characteristics of EDCs and the heterogeneity of studies, it is necessary to design specific studies of effect tracking and, in particular, education about daily preventive exposure to EDCs for the preservation of long-term public health.

Keywords

Bisphenols
Parabens
Triclosan
Phthalates
Obesity
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcIntroduction

Excess body weight as well as the environmental excesses of different contaminants are accompanied by different cardiovascular and/or reproductive health problems [2], [64, 65, 73]. The environmental pollutants interrupting the endocrine system known as endocrine disrupting chemicals (EDCs) are associated with reproductive complications, hormone-sensitive cancers, problems with thyroid function, changes in neuroendocrine systems and microbiota, diabetes, and obesity [23, 47]. The general objective to minimize EDC exposure and body burden is one of the central goals of the European regulation [4, 17, 42]. Recent findings suggest that EDCs, especially bisphenol A (BPA), correlate during all life stages with increased body weight and/or body mass index, adipogenesis, adipose tissue inflammation, lipids, and glucose dysregulation, thus contributing to weight gain and pathophysiology of obesity [13, 37, 42, 43, 47, 52, 55, 58].

Environmental stressors such as EDCs are classified as potential diabetogenic, obesogenic, carcinogenic substances related to obesity, but more profound conclusions based on experimental human studies are required to understand possible mechanisms of related disease development later in life [29, 47]. Studies have demonstrated that the EDCs can bind to different hormone receptors, mostly those for estrogens, with specific agonistic or antagonistic effects and responses [14], [35]. The estrogens preserve the integrity of energy homeostasis at central and peripheral levels via nuclear and extranuclear pathways in both females and males [46]. Moreover, some studies have confirmed that BPA exerts its disrupting effects on the classical nuclear receptors such as estrogen receptors alpha and beta (ERa and ERb), the non-classical membrane estrogen receptor (ncmER), the estrogen-related receptor gamma (ERRg), the G protein-coupled receptor 30 (GPR30), and the aryl hydrocarbon receptor (AhR) [1], [52]. Through these interactions, EDCs are assumed to be involved in the onset of the metabolic dysfunction [4, 42] through different responses in the human body (Fig. 1).Fig. 1 EDCs have an ability to bind to different hormone receptors

Moreover, structural similarities of BPA with other bisphenols such as (BP)S have raised several concerns and emphasized the need for evaluation of potential toxicity at different doses [6]. This review identifies several environmental EDCs presented in daily life (such as bisphenols—bisphenol A (BPA), bisphenol F (BPF), and bisphenol S (BPS), parabens, phthalates, and triclosan), which have already been included in the studies on obesity development, potentially also weight-loss regimen (Fig. 2).Fig. 2 The purposed model of potential physiological associations of EDCs with the obesity in humans

This review article focuses on the following endocrine disrupting chemicals:

Bisphenols

Bisphenol A (BPA; 4,4′-(Propane-2,2-diyl) diphenol; C15H16O2) is a synthetic chemical compound which was developed in the 1890s and its effect on estrogen activity was recognized in the 1930s [60]. BPA has been used in many consumer products including plastic (as a polymer), polycarbonate plastic (PVC), food packaging, dental sealants, and thermal receipts. Humans are exposed to BPA through their diet, inhalation of household dust, and dermal exposure [10, 72]. Moreover, due to health concerns BPA has largely been replaced by bisphenol F (BPF; 4,4′-Methylenediphenol; C13H12O2) and bisphenol S (BPS; 4,4′-Sulfonyldiphenol; C12H10O4S), which has resulted in the increased production of BPF and BPS over the last few decades [18]. However, it has been found that other bisphenols are toxic and have the potential to interrupt the metabolic action just as BPA, with some even exceeding that of BPA [68], [6], [42].

Parabens

Parabens (PBs), chemically a series of parahydroxybenzoates or esters of parahydroxybenzoic acid (also known as 4-hydroxybenzoic acid) include a group of chemicals which are used as preservatives in the food, cosmetic and pharmaceutical industries [11]. Their estrogenic effects were associated with the endocrine organs and other tissues, including adipose tissue. Several of these chemicals are known to cause obesogenic effects. In some experimental studies, it has been found that there are some important connections between methylparaben exposure and adipsin, affecting energy balance in the body and metabolic health, thus indicating its obesogenic potential [36]. In human biomonitoring, PB levels were associated with canned food and the use of personal care products such as makeup and skin products [62, 65].

Triclosan

Triclosan (TCS; 5-Chloro-2-(2,4-dichlorophenoxy) phenol; C12H7Cl3O2) developed in 1966 (Boyce & Pittet, 2002) is usually found in personal care products as an antibacterial agent. In animal studies, TCS exposure was associated with androgenic and thyroid disturbance, contact dermatitis, and skin irritation [66]. Beside the estrogenic and androgenic effects in mammals, some studies suggest the potential of TCS to trigger antibiotic resistance [22, 61].

Phthalates

Phthalates, esters of phthalic acid (C6H4(CO2H)2), are chemicals used to improve the utility of plastic and personal care products in daily life [38]. High-molecular-weight phthalates can enable flexibility of plastic and are used as components in toys, building materials, medical devices, and paints. Meanwhile, low-molecular-weight phthalates are usually used as components of personal care products and cosmetics such as shampoos, lotions, nail care products, and other personal hygiene products. In general, phthalates or even more a prominent sum of phthalate metabolites are the well-known EDCs with possible estrogenic and/or anti-androgenic reproductive effects [27], [40],). Moreover, the influence of combined phthalates has been related to metabolic disturbances that may interfere with obesity development (Milošević et al., 2019; [51]).

Materials and methods

This scoping review was performed in accordance with the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA, Fig. 3) guideline [67]. We conducted an electronic literature search utilizing the National Library of Medicine (PubMed) database. The following medical subject heading (MESH) keywords were used to search for studies reporting on the role of environmental endocrine disruptors in the occurrence of obesity: “endocrine disrupting chemicals” AND “obesity”.Fig. 3 PRISMA flow diagram of the study selection process. Association of endocrine disrupting chemicals with obesity

Selected literature

The focus of literature selection was to investigate the effects of EDCs such as BPA, parabens, phthalates and triclosan in studies. The database was searched for studies published in the decade from December 2013 to December 2023. The studies included were meta-analyses and systematic reviews. Due to numerous numbers of experimental studies on different EDCs which are methodologically heterogenic and need to be interpreted with caution, we focused only on systematic review studies and meta-analyses involving the selected EDCs (bisphenols, parabens, phthalates, triclosan) and obesity associations found through the inclusion criteria. The studies published in languages other than English were excluded from this review. We also performed a hand search of the reference lists of full-text articles that met our criteria in the primary literature search. All manuscripts and abstracts were independently reviewed by investigators for possible study inclusion regarding their subject and quality. Studies and manuscripts were confirmed by all researchers included.

Data extraction

After the primary search, we identified 249 potentially eligible citations (Full text, Clinical Trial, Meta-Analysis, Randomized Controlled Trial, Review, Systematic Review, Humans, English, from 2013/12/31–2023/12/31). Among those, 238 were Review studies and the rest were meta-analyses and systematic review studies (n = 20) which we included in the detailed review. Based on our inclusion criteria, we selected 10 studies which were meta-analyses and systematic review studies for detailed screening. By reviewing the reference lists of selected studies, we detected no additional and/or potentially eligible citations. Studies that met our inclusion criteria identified possibble association of exposure to main EDCs (bisphenols, parabens, triclosans and phthalates) with obesity and health related risks (Table 1). Figure 3 presents a PRISMA flow diagram of the association of EDCs with obesity.Table 1 The possible effects of endocrine disrupting chemicals on obesity in the review studies

First author, year	Study design, sample size	Analysis, exposure	Outcome assessment	Conclusions	
Ribeiro et al. [59]	Systematic Review,

Meta-analysis including

73 studies on (mostly cross-sectional design)

	Addressing an association of EDCs and anthropometric measures of obesity/body fat	EDCs (BPA, phthalates, parabens) and obesity level or body fat	BPA and phthalates associated with general and abdominal obesity	
Lee et al. [42]	Systematic Review,

Meta-analysis including

22 longitudinal and 17 cross-sectional studies

	Analyses of prenatal and postnatal EDCs exposure association with growth disturbances	EDCs (phthalate) exposure and body mass index (BMI) and fat mass	Prenatal

phthalate exposure associated with low BMI, but not with body fat mass

	
[33]	Meta-analysis including

16 studies (12 cross-sectional, 2 case–control, 1 prospective study)

	Risk evaluation of T2DM and BPA	Urine and serum EDCs (BPA), T2DM	BPA exposure positively associated with T2DM risk in humans	
[20]	Meta-analysis including

99 studies (17 cohort, 15 cross-sectional, 3 case–control studies)

	Association analyses between EDCs and cardiometabolic risk factors	EDCs (phthalates), obesity level in children and adolescents	A positive association between phthalate and some cardiometabolic risk factors	
[69]	Systematic review of cross-sectional (n = 17) and cohort studies (n = 18) were identified that reported on associations between pollutants and obesity measures	Association analyses between EDCs and obesity	EDCs (BPA, others) and obesity in human subjects	A positive association between pollutants, especially BPA, and obesity in humans	
[75]	A systematic review and meta-analysis of the current literature to explore the effects of phthalate exposure on obesity	Association analyses between EDCs (phthalates) and obesity	EDCs (phthalates) and obesity in children and adults	The associations exist between phthalate exposure and obesity in children and adults	
Maqbool et al. [48]	A systematic review of environmental toxicants and possible involved mechanisms	The interactions and mechanism of toxicity in relation to human general health problems	EDC risks for human by targeting different organs and systems in the body	The association between endocrine disruptions and human diseases	
[19]	A systematic literature search of the association of prenatal phthalate exposure with an absolute adiposity marker	Association analyses between EDCs (prenatal exposure) and obesity	EDCs (prenatal phthalates exposure) and obesity development	A weak relationship between phthalate exposure and children's obesity trajectory in a sex-specific manner	
Andújar et al. [3]	A literature review of the available research in humans, in in vivo and in vitro tests	Association EDCs of and analogues and the associated health effects	EDCs (BPA, BPA analogues) and obesogenic effects	BPA analogues may have an impact on human health, especially in terms of obesity and other adverse health effects in children	
Gutiérrez-Torres et al.,[25]	A systematic review from 16 cohort studies were identified and reviewed	Association between prenatal exposure to EDCs in preschoolers	EDCs (BPA, phthalates) impact on the anthropometric variables and biochemical parameters	EDCs is positively associated with cardiometabolic risk factors	
EDCs Endocrine disrupting chemicals, T2DM Type 2 diabetes mellitus, BMI Body mass index.

Results

The studies have identified possible association of obesity with the exposure to endocrine disrupting chemicals (EDCs). The data on systematic review studies and meta -analyses are presented in Table 1.

Literature identification

The possible effects of endocrine disrupting chemicals on obesity in humans described in systematic reviews and meta-analysis are summarized in Table 1.

EDCs Endocrine disrupting chemicals; T2DM-Type 2 diabetes mellitus, BMI Body mass index.

The main conclusions of the 10 reviewed studies indicate that obesity indications might be related to EDC exposure [20, 33, 59], [3, 25, 69, 75], [19], Maqbool et al., 2016). In addition, researchers also suggested that mainly BPA and phthalates might be related to obesity and cardiometabolic risk factors and adverse health effects in children [19, 40], [3], [25]).

Discussion

Exposure to a wide range of EDCs, mainly bisphenols (BPA, BPs) and phthalates, is inevitable and inadvertent. Those EDCs are environmental endocrine disruptors which may interact in the development of obesity, specifically anthropometric alterations, metabolic disorders, reproductive system damage, and hormone-sensitive cancers [59], [3, 69, 75], [33]. EDC exposure observations proved the association of a vulnerable prenatal group with exposure to environmental pollutants, which may have important health consequences later in life [19, 40], [25] [20]. Therefore, it is extremely important to pay attention even to environmental factors in the prevention of obesity, which, with long-term exposure, can affect the development and course of the hormonal state and can inhibit body weight regulation through various mechanisms (Maqbool et al., 2016). Several meta-analyses and systematic reviews have analyzed and evaluated the relationship of mainly bisphenols and phthalates while less is yet discovered regarding other EDCs, such as triclosans and parabens.

Environmental stressors such as EDCs with broad health implications, including the potential development of obesity related diseases and performance limitations, should not be neglected. This review argues the importance of environmental exposure control as a tool to promote obesogenic as well as diabetogenic, and carcinogenic health prevention. Research findings emphasize close relation of the most prominent environmental pollutants, their mixtures and metabolites as a potential additional obesogenic substance. Assessing the full impact of human exposure to EDCs is challenging because the adverse effects develop latently and manifest at different ages, although preclinical and clinical evidence suggests that developing fetuses and neonates are most vulnerable to endocrine disruption (Modica et al., 2023). Therefore, the growing evidence supports the urgent need to reduce exposure to EDCs with healthy choices on a daily basis and at the same time to decrease the EDCs’ negative effects.

The importance of EDCs for vulnerable health groups

As obesity increases, the incidence of cardiovascular disease, type 2 diabetes, obesity-related cancers, osteoarthritis, and psychological disorders increases [16], [45]. Obesity clearly has a measurable impact on physical and mental health and the quality of life, and causes significant direct and indirect costs. Obesity is also associated with environmental pollutants such as bisphenols, mainly BPA, which disturb the hormonal balance and can be passed on to future generations in the vulnerable health group in the reproductive period [34] through epigenetic programming, during the sensitive time for obesogenic action in the womb and early childhood [31]. Moreover, prenatal life exposure to EDCs was associated with low body mass index (BMI) in newborns [40] with increased susceptibility to diseases or disfunctions and susceptibility to gain more weight than babies with normal body weight across the life course [56], [28]; [30, 71]. Metabolic disturbances related to obesity development induced by a mixture of chemical compounds people are daily exposed to have the capacity to interfere with the endocrine axis at different levels and might even have carcinogenic effects. While some EDCs have already been linked to the development of breast and thyroid cancer (like dioxin and cadmium), prostate cancer (arsenic, asbestos, and dioxin), and testicular cancer (organochlorines/organohalogens), new evidence supports the role of the remaining EDCs as possible carcinogens, thus it is recommended for pregnant women to avoid the risk area and exposure [54]. Moreover, researchers showed that BPA exposure was significantly associated with higher thyroid stimulating hormone levels in overweight/obese subjects suggesting that BPA exposure is a risk factor for thyroid cancer in overweight/obese subjects [47]. The effect modification observed in the group with body mass index (BMI) ≥ 25 kg/m2 confirms the relation between body weight and the importance of normal BMI control. Furthermore, malignancy risk for breast cancer was associated with parabens [26].

EDC evaluations and monitoring of effects

The European Union reports (ANSES, 2014; EFSA, 2015; ECHA, 2015) have already assessed the effect on BPA on metabolism, obesity and metabolic disorders, confirming diabetogenic and obesogenic effects [3]. The similarity of the bisphenol BPA with other bisphenols, such as BPS, also causes great concern in the European Union. Indeed, toxicokinetic data showed a 100-fold higher oral bioavailability of BPS than BPA compared to BPA in a pig model [6]. The data observed with adverse effects for BPS at much lower doses calls for the protection of humans by proposing reference values. In the determination of environmental doses the need to link the exposure to human diseases and to include exposomics in the characterization of environment-related pathologies together with genomics and other omics has already been expressed [5, 31]. Additionally, evidence pointing to the fact that low-level exposure to multiple chemicals can be associated with metabolic disturbances under conditions where no effect would be expected when considering the concentration of each individual chemical in the mixture, means that assessment procedures must also consider the possibility of a mixture of pollutants, i.e. the so-called cocktail effect [42]. Furthermore, EDCs, especially phthalates, can exhibit synergistic and additive effects due to their similar molecular structure and mechanism of action, therefore mixtures of phthalates increase the disruptive effects, indicating that the sum of phthalate metabolites is more important than the individual ones and may be associated with oestrogenic and/or anti-androgenic reproductive effects in adolescent girls [27]. Moreover, the evidence that combined phthalates may influence glucose and lipid metabolism which can also increase insulin resistance highlights the association of EDCs with obesity [53]. It has also been shown that increased concentrations of phthalate metabolites can influence obesity, glucose and lipid impairment in women with polycystic ovary syndrome. The authors demonstrated that urinary concentrations of total phthalate metabolites were positively associated with BMI, waist circumference, waist-to-height ratio, serum leptin and lipid storage product levels, and visceral fat index, which further emphasizes the importance of BMI awareness for obesity prevention [51].

EDCs during weight loss protocols

Obesity and overweight identification, treatment, and prevention present major public health challenges in multiple perspectives on a global scale [74]. The physiopathology and clinical impacts of excess body fat are understood insufficiently, and there are many difficulties in developing safe and effective long-term therapeutic strategies [32]. Specifically, in metabolically unhealthy obese persons higher blood levels of EDCs were observed compared to metabolically healthy obese persons,the levels were not changed after weight loss protocols [15], or they even increased as weight loss occurred [9]. The results of a higher level of EDCs associated with greater weight regain and greater decrease in resting metabolic rate [44] reflects the association of the importance to avoid EDCs to prevent obesity. The association of EDCs, specifically BPA, with obesity can also be explained by evidence of the presence of molecular changes which could cause metabolic disorders and affect the action of estrogen in metabolism [50]. For the purpose of controlling body weight, potential vitamin supplements have also been tested to reduce the toxic effects of EDCs, which needs further research [24]. The conclusions of review studies suggest the involvement of EDCs in the development of obesity [33], [15], [20], Riberiro et al., 2020, Wasseraar & Legler, 2018) observed by generalized and abdominal obesity (Ribeiro, 2020).

EDCs as a lipophilic environmental toxicant

EDCs may have short half-lives. Some are lipophilic and can as such bio-accumulate in adipose tissues, thus presenting increasing health hazards in individuals with excess body weight [9]. Weight loss has been related to the release and redistribution of organic pollutants to other lipid-rich organs such as the brain, kidney, and liver, which needs further investigation [9]. It has been suggested that even weight control interventions should be considered to limit organ exposure to pollutants when planning weight loss protocols [9], [12]. Moreover, in diet induced weight-loss higher baseline plasma EDCs concentrations have significantly been associated with greater weight regain, especially in women, accompanied by a slower regression of resting metabolic rate [44]. It is necessary to understand the complexity of the mechanisms involved in differentiation of fat cells and the influence of EDCs in the adipogenesis and the etiology of obesity [21]. The findings indicate a significant association between exposure to BPA and obesity in adults, but are insufficient to support that EDCs cause obesity “per se” in humans due to the cross-sectional design of most included studies [59]. González-Casanova et al. [21] reported that EDCs can alter lipid metabolism, promote fat accumulation, and interfere with processes such as adipogenesis through the immunomodulation effects and other mechanisms of action, such as microbiota and epigenetics. Findings on immune and inflammatory responses of animals support the idea that further investigations are needed in humans to better understand the health consequences of EDCs exposure.

BPA in obesity prevention

Humans may be exposed to more EDCs at the same time and exposure varies over time, which makes it impossible to evaluate their potential synergistic or antagonistic effects. Furthermore, it is important for EDCs to have sometimes a short urinary elimination half-life in the human body, and sometimes they don’t. Therefore, it may be necessary to consider whether a single urine or blood sample is representative of the overall exposure of an individual, including the subjective level of daily environmental exposure. EDCs act via various hormone receptors through a variety of known and unknown mechanisms including epigenetic modifications. They differ from classic toxins in several ways such a slow-dose effect (time after exposure), non-monotonic dose and trans-generational effects. Therefore, more studies are warranted to elucidate the mechanisms functioning as the link between EDC exposure and metabolic health [44]. In addition, trans-generational inheritance and bioaccumulation of EDCs are among clear obstacles for new research evidence [39]. Specifically, the results of reviewed studies have suggested that mainly BPA is associated with obesity development which may negatively affect the metabolic functions in various ways. Some epidemiological studies using data from the National Health and Nutrition Examination Survey (NHANES) have reported that higher urine BPA concentrations tend to be correlated with greater obesity risk and waist circumference [63], [7]. Researchers confirmed a significant relationship between BPA and childhood obesity [35]. They also described the role of BPA in modulating canonical endocrine function, which regulates the metabolism during childhood. It was reported that BPA at environmental doses acts in mature adipocytes by modulating gene expression which leads to molecular changes promoting metabolic disorders in children. The persistence of BPA in the environment and in the human adipose tissue might be an important risk factor and a strong argument for further research of the development of obesity [50].

Phthalates and parabens in obesity prevention

Wassenaar & Legler [71] reported that early-life exposure of animals to phthalates is associated with increased fat weight, while non-significant negative association was related to body weight. On the other hand, studies on the connection between exposure to phthalates in childhood and obesity were inconsistent. Specifically, prenatal phthalate exposure may disturb the normal growth of children by decreased BMI rather than causing obesity, as hypothesized by previous studies [40]. Moreover, it has recently been discovered that BPA and phthalates are cardiovascular disruptors and BPA by itself could have a direct relationship with systemic inflammation regardless of obesity or insulin resistance.

Parabens were related to obesogenic potential affecting energy balance and metabolic health [36]. While contradictory results were obtained regarding triclosan and obesity, one of the recent animal studies has emphasized the underlying toxic obesogenic mechanism of triclosan which is based on gut-brain axis [70]. However, due to inconclusive outcomes regarding phthalates and parabens further research is needed.

Future prospectives to prevent EDCs' negative health effects

Increased exposure to EDCs could pose long-term health risk effects. EDCs are ubiquitous contaminants with a broad spectrum of effects. The chemicals such as BPA, parabens, triclosan and phthalates are common environmental pollutants incriminated for metabolic as well as reproductive disorders. Therefore, most published literature concerning EDCs and obesity focuses mainly on BPA with diabetogenic, obesogenic and carcinogenic effects which need further investigation regarding their mechanisms. Therefore, human research combining biomonitoring, analyses of biological samples, and a structured questionnaire on the quality of life, food and physical activity to evaluate the association between lifestyle variables potentially related to different EDCs, mixtures of EDCs and their metabolites could present one of the possible designs of a more profound strategy to understand the long-term association of EDCs and obesity.

Collectively, the data indicates that endocrine disruptors may interfere with mechanisms regulating body weight through various physiological pathways, potentially leading to obesity. The conclusions might thus serve as a precaution to avoid the exposure of EDCs in daily life. This is particularly important in the current worldwide scenario of ongoing exposure of children and adults to EDCs, not only to chemicals which are still used for a wide range of purposes, but also to compounds which were banned in many countries but have a persistent and ubiquitous occurrence in the environment. To better illuminate the environmental triggers of obesity, further studies on larger populations are needed.

Summary

In this review, we summarized the knowledge on the association of EDCs such as BPA, parabens, triclosan and phthalates with obesity in the last 10 years. Revealed studies, methodologically heterogenic, have reported a potential association between prolonged exposure to EDCs and obesity. However, the main findings of this review need to be interpreted with caution due to the used methodology investigating EDCs and obesity, the selected database, and heterogenous experimental studies that were not included. Recent research indicates that there is a specific need to combine human biomonitoring with other investigating methods to evaluate the quality of life including exposure to environmental triggers such as plastic and personal hygiene products of the observed population. More studies on molecular effects are needed to understand the association of EDCs with metabolic diseases, particularly human obesity. The exposure of environmental triggers and possible associations with human performance and disease prevention should not be neglected.

Limitations

The literature search scoping review was limited to a single database and to publications available entirely in the English language, potentially excluding valuable research conducted in other languages and from other databases. Lastly, our results are only up to date as of December 2023, and any subsequent studies beyond this timeframe are not incorporated into our review.

Conclusion

Regardless of some inconsistences in the findings across summarized studies, involuntary exposure to EDCs might be related with obesity development. Further studies including multicentric studies are needed to delineate exact mechanisms through which EDC exposure causes obesity, so that efficient preventative measures could be implemented. The lack of public knowledge about the effects of EDCs on human health is concerning, which should encourage health care providers to inform especially a specific health population or ergonomically demanding populations to avoid the excess body weight and possible EDC exposure, thus empowering them to make healthier choices.

Author contributions

All authors have contributed to the article, read manuscript, agreed with the content, and approved the submitted version. Authors confirm that the manuscript is original and has not been published in a journal and is not currently under consideration by another journal. MA collected the data for paper, coordinated and contributed at all stages of the review and critically reviewed the final review. TK contributed to the writing of the review and contributed to the strategy development and in all stages of the review. IVK contributed to the writing of the paper and participated in all stages of data collection.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Availability of data and materials

No datasets were generated or analysed during the current study.

Declarations

Competing interests

The authors declare no competing interests.

Consent for publication

Not applicable.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. Alonso-Magdalena P Ropero AB Soriano S García-Arévalo M Ripoll C Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways Mol Cell Endocrinol 2012 355 2 201 207 10.1016/j.mce.2011.12.012 22227557
Alonso-Magdalena P, Ropero AB, Soriano S, García-Arévalo M, Ripoll C, et al. Bisphenol-A acts as a potent estrogen via non-classical estrogen triggered pathways. Mol Cell Endocrinol. 2012;355(2):201–7. 10.1016/j.mce.2011.12.012.22227557 10.1016/j.mce.2011.12.012
2. Amato AA Wheeler HB Blumberg B Obesity and endocrine-disrupting chemicals Endocr Connect 2021 10 2 R87 R105 10.1530/EC-20-0578 33449914
Amato AA, Wheeler HB, Blumberg B. Obesity and endocrine-disrupting chemicals. Endocr Connect. 2021;10(2):R87–105. 10.1530/EC-20-0578.33449914 10.1530/EC-20-0578
3. Andújar N Gálvez-Ontiveros Y Zafra-Gómez A Rodrigo L Álvarez-Cubero MJ Aguilera M Monteagudo C Rivas AA Bisphenol a analogues in food and their hormonal and obesogenic effects: a review Nutrients 2019 11 9 2136 10.3390/nu11092136.PMID:31500194;PMCID:PMC6769843 31500194
Andújar N, Gálvez-Ontiveros Y, Zafra-Gómez A, Rodrigo L, Álvarez-Cubero MJ, Aguilera M, Monteagudo C, Rivas AA. Bisphenol a analogues in food and their hormonal and obesogenic effects: a review. Nutrients. 2019;11(9):2136. 10.3390/nu11092136.PMID:31500194;PMCID:PMC6769843.31500194 10.3390/nu11092136.PMID:31500194;PMCID:PMC6769843
4. Anses. Annex XV Restriction report—proposal for a restriction–4.4’-isopropylidenediphenol (Bisphenol a; BPA), 2014.
5. Barouki R Samson M Blanc EB Colombo M Zucman-Rossi J Lazaridis KN Miller GW Coumoul X The exposome and liver disease-how environmental factors affect liver health J Hepatol 2023 79 2 492 505 10.1016/j.jhep.2023.02.034 36889360
Barouki R, Samson M, Blanc EB, Colombo M, Zucman-Rossi J, Lazaridis KN, Miller GW, Coumoul X. The exposome and liver disease-how environmental factors affect liver health. J Hepatol. 2023;79(2):492–505.36889360 10.1016/j.jhep.2023.02.034
6. Beausoleil C Le Magueresse-Battistoni B Viguié C Babajko S Canivenc-Lavier MC Chevalier N Emond C Habert R Picard-Hagen N Mhaouty-Kodja S Regulatory and academic studies to derive reference values for human health: the case of bisphenol S Environ Res 2022 1 204 112233 10.1016/j.envres.2021.112233
Beausoleil C, Le Magueresse-Battistoni B, Viguié C, Babajko S, Canivenc-Lavier MC, Chevalier N, Emond C, Habert R, Picard-Hagen N, Mhaouty-Kodja S. Regulatory and academic studies to derive reference values for human health: the case of bisphenol S. Environ Res. 2022;1(204):112233.10.1016/j.envres.2021.112233
7. Bhandari R Xiao J Shankar A Urinary bisphenol A and obesity in US children Am J Epidemiol 2013 177 11 1263 1270 10.1093/aje/kws391 23558351
Bhandari R, Xiao J, Shankar A. Urinary bisphenol A and obesity in US children. Am J Epidemiol. 2013;177(11):1263–70. 10.1093/aje/kws391.23558351 10.1093/aje/kws391
8. Boyce JM, Pittet D. Healthcare Infection Control Practices Advisory, Committee.; HICPAC/SHEA/APIC/IDSA hand hygiene task, force. "Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America". MMWR. Recommendations and Reports. 2002; 51(RR-16): 1–45, quiz CE1–4.
9. Brown RH Ng DK Steele K Schweitzer M Groopman JD Mobilization of environmental toxicants following bariatric surgery Obesity (Silver Spring) 2019 27 11 1865 1873 10.1002/oby.22618 31689012
Brown RH, Ng DK, Steele K, Schweitzer M, Groopman JD. Mobilization of environmental toxicants following bariatric surgery. Obesity (Silver Spring). 2019;27(11):1865–73. 10.1002/oby.22618.31689012 10.1002/oby.22618
10. Carwile JL Luu HT Bassett LS Driscoll DA Yuan C Polycarbonate bottle use and urinary bisphenol A concentrations Environ Health Perspect 2009 117 9 1368 1372 10.1289/ehp.0900604 19750099
Carwile JL, Luu HT, Bassett LS, Driscoll DA, Yuan C, et al. Polycarbonate bottle use and urinary bisphenol A concentrations. Environ Health Perspect. 2009;117(9):1368–72. 10.1289/ehp.0900604.19750099 10.1289/ehp.0900604
11. Cashman AL Warshaw EM Parabens: a review of epidemiology, structure, allergenicity, and hormonal properties Dermatitis 2005 16 2 57 66 10.2310/derm.1.2005.2050 16036114
Cashman AL, Warshaw EM. Parabens: a review of epidemiology, structure, allergenicity, and hormonal properties. Dermatitis. 2005;16(2):57–66. 10.2310/derm.1.2005.2050.16036114 10.2310/derm.1.2005.2050
12. Dabas J Shunmukha Priya S Alawani A Budhrani P What could be the reasons for not losing weight even after following a weight loss program? J Health Popul Nutr 2024 43 1 37 10.1186/s41043-024-00516-4.PMID:38429842;PMCID:PMC10908186 38429842
Dabas J, Shunmukha Priya S, Alawani A, Budhrani P. What could be the reasons for not losing weight even after following a weight loss program? J Health Popul Nutr. 2024;43(1):37. 10.1186/s41043-024-00516-4.PMID:38429842;PMCID:PMC10908186.38429842 10.1186/s41043-024-00516-4.PMID:38429842;PMCID:PMC10908186
13. Darbre PD Endocrine disruptors and obesity Curr Obes Rep 2017 6 1 18 27 10.1007/s13679-017-0240-4 28205155
Darbre PD. Endocrine disruptors and obesity. Curr Obes Rep. 2017;6(1):18–27. 10.1007/s13679-017-0240-4.28205155 10.1007/s13679-017-0240-4
14. De Coster S, Van Larebeke N. Endocrine-disrupting chemicals: associated disorders and mechanisms of action. J Environ Public Health. 2012; 713696. 10.1155/201
15. Dirinck EL Dirtu AC Govindan M Covaci A Jorens PG Endocrine-disrupting polychlorinated biphenyls in metabolically healthy and unhealthy obese subjects before and after weight loss: difference at the start but not at the finish Am J Clin Nutr 2016 103 4 989 998 10.3945/ajcn.115.119081 26961932
Dirinck EL, Dirtu AC, Govindan M, Covaci A, Jorens PG, et al. Endocrine-disrupting polychlorinated biphenyls in metabolically healthy and unhealthy obese subjects before and after weight loss: difference at the start but not at the finish. Am J Clin Nutr. 2016;103(4):989–98. 10.3945/ajcn.115.119081.26961932 10.3945/ajcn.115.119081
16. Dixon JB The effect of obesity on health outcomes Mol Cell Endocrinol 2010 316 2 104 108 10.1016/j.mce.2009.07.008 19628019
Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol. 2010;316(2):104–8. 10.1016/j.mce.2009.07.008. (Epub 2009 Jul 21 PMID: 19628019).19628019 10.1016/j.mce.2009.07.008
17. EP, Endocrine Disruptors: from Scientific Evidence to Human Health Protection (2019–2023). Policy department for citizens' rights and constitutional affairs. European Parliament; [Accessed 2023, Oct 2].2019; https://www.europarl.europa.eu/RegData/etudes/STUD/2019/608866/IPOL_STU(2019)608866_EN.pdf
18. Fürhacker M Scharf S Weber H Bisphenol A: emissions from point sources Chemosphere 2000 41 5 751 756 10.1016/s0045-6535(99)00466-x 10834378
Fürhacker M, Scharf S, Weber H. Bisphenol A: emissions from point sources. Chemosphere. 2000;41(5):751–6. 10.1016/s0045-6535(99)00466-x.10834378 10.1016/s0045-6535(99)00466-x
19. Gao H Wang YF Wang ZW Wang Y Tao FB Prenatal phthalate exposure associated with age-specific alterations in markers of adiposity in offspring: a systematic review Ecotoxicol Environ Saf 2022 1 232 113247 10.1016/j.ecoenv.2022.113247
Gao H, Wang YF, Wang ZW, Wang Y, Tao FB. Prenatal phthalate exposure associated with age-specific alterations in markers of adiposity in offspring: a systematic review. Ecotoxicol Environ Saf. 2022;1(232):113247. 10.1016/j.ecoenv.2022.113247.10.1016/j.ecoenv.2022.113247
20. Golestanzadeh M Riahi R Kelishadi R Association of exposure to phthalates with cardiometabolic risk factors in children and adolescents: a systematic review and meta-analysis Environ Sci Pollut Res Int 2019 26 35 35670 35686 10.1007/s11356-019-06589-7 31728953
Golestanzadeh M, Riahi R, Kelishadi R. Association of exposure to phthalates with cardiometabolic risk factors in children and adolescents: a systematic review and meta-analysis. Environ Sci Pollut Res Int. 2019;26(35):35670–86. 10.1007/s11356-019-06589-7.31728953 10.1007/s11356-019-06589-7
21. González-Casanova JE Pertuz-Cruz SL Caicedo-Ortega NH Rojas-Gomez DM Adipogenesis regulation and endocrine disruptors: emerging insights in obesity Biomed Res Int 2020 18 7453786 10.1155/2020/7453786
González-Casanova JE, Pertuz-Cruz SL, Caicedo-Ortega NH, Rojas-Gomez DM. Adipogenesis regulation and endocrine disruptors: emerging insights in obesity. Biomed Res Int. 2020;18:7453786. 10.1155/2020/7453786.10.1155/2020/7453786
22. Goodman M Naiman DQ LaKind JS Systematic review of the literature on triclosan and health outcomes in humans Crit Rev Toxicol 2018 48 1 1 51 10.1080/10408444.2017.1350138 28741979
Goodman M, Naiman DQ, LaKind JS. Systematic review of the literature on triclosan and health outcomes in humans. Crit Rev Toxicol. 2018;48(1):1–51. 10.1080/10408444.2017.1350138.28741979 10.1080/10408444.2017.1350138
23. Gore AC Chappell VA Fenton SE Flaws JA Nadal A EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals Endocr Rev 2015 36 6 1 150 10.1210/er.2015-1010 25202833
Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, et al. EDC-2: the endocrine society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015;36(6):1–150. 10.1210/er.2015-1010.25202833 10.1210/er.2015-1010
24. Guo W, Huen K, Park JS, Petreas M, Crispo et al. Vitamin C intervention may lower the levels of persistent organic pollutants in blood of healthy women—a pilot study. Food Chem Toxicol. 2016; 92:197–204. 10.1016/j.fct.2016.04.006
25. Gutiérrez-Torres DS Barraza-Villarreal A Hernandez-Cadena L Escamilla-Nuñez C Romieu I Prenatal exposure to endocrine disruptors and cardiometabolic risk in preschoolers: a systematic review based on cohort studies Ann Glob Health 2018 84 2 239 249 10.29024/aogh.911.PMID:30873814;PMCID:PMC6748211 30873814
Gutiérrez-Torres DS, Barraza-Villarreal A, Hernandez-Cadena L, Escamilla-Nuñez C, Romieu I. Prenatal exposure to endocrine disruptors and cardiometabolic risk in preschoolers: a systematic review based on cohort studies. Ann Glob Health. 2018;84(2):239–49. 10.29024/aogh.911.PMID:30873814;PMCID:PMC6748211.30873814 10.29024/aogh.911.PMID:30873814;PMCID:PMC6748211
26. Hager E Chen J Zhao L Minireview: parabens exposure and breast cancer Int J Environ Res Public Health 2022 19 3 1873 10.3390/ijerph19031873.PMID:35162895;PMCID:PMC8834979 35162895
Hager E, Chen J, Zhao L. Minireview: parabens exposure and breast cancer. Int J Environ Res Public Health. 2022;19(3):1873. 10.3390/ijerph19031873.PMID:35162895;PMCID:PMC8834979.35162895 10.3390/ijerph19031873.PMID:35162895;PMCID:PMC8834979
27. Hart R Doherty DA Frederiksen H Keelan JA Hickey M Sloboda D Pennell CE Newnham JP Skakkebaek NE Main KM The influence of antenatal exposure to phthalates on subsequent female reproductive development in adolescence: a pilot study Reproduction 2014 147 4 379 390 10.1530/REP-13-0331 24025997
Hart R, Doherty DA, Frederiksen H, Keelan JA, Hickey M, Sloboda D, Pennell CE, Newnham JP, Skakkebaek NE, Main KM. The influence of antenatal exposure to phthalates on subsequent female reproductive development in adolescence: a pilot study. Reproduction. 2014;147(4):379–90. 10.1530/REP-13-0331. (PMID: 24025997).24025997 10.1530/REP-13-0331
28. Haugen AC Schug TT Collman G Heindel JJ Evolution of DOHaD: the impact of environmental health sciences J Dev Orig Health Dis 2015 6 2 55 64 10.1017/S2040174414000580 25471238
Haugen AC, Schug TT, Collman G, Heindel JJ. Evolution of DOHaD: the impact of environmental health sciences. J Dev Orig Health Dis. 2015;6(2):55–64. 10.1017/S2040174414000580.25471238 10.1017/S2040174414000580
29. Haverinen E Fernandez MF Mustieles V Tolonen H Metabolic syndrome and endocrine disrupting chemicals: an overview of exposure and health effects Int J Environ Res Public Health 2021 18 24 13047 10.3390/ijerph182413047 34948652
Haverinen E, Fernandez MF, Mustieles V, Tolonen H. Metabolic syndrome and endocrine disrupting chemicals: an overview of exposure and health effects. Int J Environ Res Public Health. 2021;18(24):13047. 10.3390/ijerph182413047.34948652 10.3390/ijerph182413047
30. Heindel JJ Blumberg B Cave M Machtinger R Mantovani A Mendez MA Nadal A Palanza P Panzica G Sargis R Vandenberg LN Vom Saal F Metabolism disrupting chemicals and metabolic disorders Reprod Toxicol 2017 68 3 33 10.1016/j.reprotox.2016.10.001 27760374
Heindel JJ, Blumberg B, Cave M, Machtinger R, Mantovani A, Mendez MA, Nadal A, Palanza P, Panzica G, Sargis R, Vandenberg LN, Vom Saal F. Metabolism disrupting chemicals and metabolic disorders. Reprod Toxicol. 2017;68:3–33. 10.1016/j.reprotox.2016.10.001.27760374 10.1016/j.reprotox.2016.10.001
31. Heindel JJ Howard S Agay-Shay K Arrebola JP Audouze K Babin PJ Barouki R Bansal A Blanc E Cave MC Chatterjee S Chevalier N Choudhury M Collier D Connolly L Coumoul X Garruti G Gilbertson M Hoepner LA Holloway AC Howell G Kassotis CD Kay MK Kim MJ Lagadic-Gossmann D Langouet S Legrand A Li Z Le Mentec H Lind L Monica Lind P Lustig RH Martin-Chouly C Munic Kos V Podechard N Roepke TA Sargis RM Starling A Tomlinson CR Touma C Vondracek J Vom Saal F Blumberg B Obesity II: establishing causal links between chemical exposures and obesity Biochem Pharmacol 2022 199 115015 10.1016/j.bcp.2022.115015 35395240
Heindel JJ, Howard S, Agay-Shay K, Arrebola JP, Audouze K, Babin PJ, Barouki R, Bansal A, Blanc E, Cave MC, Chatterjee S, Chevalier N, Choudhury M, Collier D, Connolly L, Coumoul X, Garruti G, Gilbertson M, Hoepner LA, Holloway AC, Howell G, Kassotis CD, Kay MK, Kim MJ, Lagadic-Gossmann D, Langouet S, Legrand A, Li Z, Le Mentec H, Lind L, Monica Lind P, Lustig RH, Martin-Chouly C, Munic Kos V, Podechard N, Roepke TA, Sargis RM, Starling A, Tomlinson CR, Touma C, Vondracek J, Vom Saal F, Blumberg B. Obesity II: establishing causal links between chemical exposures and obesity. Biochem Pharmacol. 2022;199:115015. 10.1016/j.bcp.2022.115015.35395240 10.1016/j.bcp.2022.115015
32. Heymsfield SB Wadden TA Mechanisms, pathophysiology, and management of obesity N Engl J Med 2017 376 15 1492 10.1056/NEJMc1701944 28402780
Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(15):1492. 10.1056/NEJMc1701944.28402780 10.1056/NEJMc1701944
33. Hwang S Lim JE Choi Y Jee SH Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis BMC Endocr Disord 2018 18 1 81 10.1186/s12902-018-0310-y 30400886
Hwang S, Lim JE, Choi Y, Jee SH. Bisphenol A exposure and type 2 diabetes mellitus risk: a meta-analysis. BMC Endocr Disord. 2018;18(1):81. 10.1186/s12902-018-0310-y.30400886 10.1186/s12902-018-0310-y
34. Kahn LG Philippat C Nakayama SF Slama R Trasande L Endocrine-disrupting chemicals: implications for human health Lancet Diabetes Endocrinol 2020 8 8 703 718 10.1016/S2213-8587(20)30129-7.PMID:32707118;PMCID:PMC7437820 32707118
Kahn LG, Philippat C, Nakayama SF, Slama R, Trasande L. Endocrine-disrupting chemicals: implications for human health. Lancet Diabetes Endocrinol. 2020;8(8):703–18. 10.1016/S2213-8587(20)30129-7.PMID:32707118;PMCID:PMC7437820.32707118 10.1016/S2213-8587(20)30129-7.PMID:32707118;PMCID:PMC7437820
35. Kim JT Lee HK Childhood obesity and endocrine disrupting chemicals Ann Pediatr Endocrinol Metab 2017 22 219 225 10.6065/apem.2017.22.4.219 29301181
Kim JT, Lee HK. Childhood obesity and endocrine disrupting chemicals. Ann Pediatr Endocrinol Metab. 2017;22:219–25. 10.6065/apem.2017.22.4.219.29301181 10.6065/apem.2017.22.4.219
36. Kolatorova L Sramkova M Vitku J Vcelak J Lischkova O Parabens and their relation to obesity Physiol Res 2018 67 3 S465 S472 10.33549/physiolres.934004 30484673
Kolatorova L, Sramkova M, Vitku J, Vcelak J, Lischkova O, et al. Parabens and their relation to obesity. Physiol Res. 2018;67(3):S465–72.30484673 10.33549/physiolres.934004
37. Kumar M Sarma DK Shubham S Kumawat M Verma V Environmental endocrine-disrupting chemical exposure: role in non-communicable diseases Front Public Health 2020 24 8 553850 10.3389/fpubh.2020.553850
Kumar M, Sarma DK, Shubham S, Kumawat M, Verma V, et al. Environmental endocrine-disrupting chemical exposure: role in non-communicable diseases. Front Public Health. 2020;24(8):553850. 10.3389/fpubh.2020.553850.10.3389/fpubh.2020.553850
38. Kumari M Pulimi M Phthalate esters: occurrence, toxicity, bioremediation, and advanced oxidation processes Water Sci Technol 2023 87 9 2090 2115 10.2166/wst.2023.119 37186617
Kumari M, Pulimi M. Phthalate esters: occurrence, toxicity, bioremediation, and advanced oxidation processes. Water Sci Technol. 2023;87(9):2090–115. 10.2166/wst.2023.119.37186617 10.2166/wst.2023.119
39. Lauretta R Sansone A Sansone M Romanelli F Appetecchia M Endocrine disrupting chemicals: effects on endocrine glands Front Endocrinol 2019 10 178 10.3389/fendo.2019.00178
Lauretta R, Sansone A, Sansone M, Romanelli F, Appetecchia M. Endocrine disrupting chemicals: effects on endocrine glands. Front Endocrinol. 2019;10:178. 10.3389/fendo.2019.00178.10.3389/fendo.2019.00178
40. Lee DW Lim HM Lee JY Min KB Shin CH Prenatal exposure to phthalate and decreased body mass index of children: a systematic review and meta-analysis Sci Rep 2022 12 1 8961 10.1038/s41598-022-13154-9 35624195
Lee DW, Lim HM, Lee JY, Min KB, Shin CH, et al. Prenatal exposure to phthalate and decreased body mass index of children: a systematic review and meta-analysis. Sci Rep. 2022;12(1):8961. 10.1038/s41598-022-13154-9.35624195 10.1038/s41598-022-13154-9
41. Le Magueresse-Battistoni B Multigner L Beausoleil C Rousselle C Effects of bisphenol A on metabolism and evidences of a mode of action mediated through endocrine disruption Mol Cell Endocrinol 2018 5 475 74 91 10.1016/j.mce.2018.02.009
Le Magueresse-Battistoni B, Multigner L, Beausoleil C, Rousselle C. Effects of bisphenol A on metabolism and evidences of a mode of action mediated through endocrine disruption. Mol Cell Endocrinol. 2018;5(475):74–91. 10.1016/j.mce.2018.02.009. (Epub 2018 Feb 23 PMID: 29481862).10.1016/j.mce.2018.02.009
42. Le Magueresse-Battistoni B Vidal H Naville D Environmental pollutants and metabolic disorders: the multi-exposure scenario of Life Front Endocrinol (Lausanne) 2018 2 9 582 10.3389/fendo.2018.00582.PMID:30333793;PMCID:PMC6176085
Le Magueresse-Battistoni B, Vidal H, Naville D. Environmental pollutants and metabolic disorders: the multi-exposure scenario of Life. Front Endocrinol (Lausanne). 2018;2(9):582. 10.3389/fendo.2018.00582.PMID:30333793;PMCID:PMC6176085.10.3389/fendo.2018.00582.PMID:30333793;PMCID:PMC6176085
43. Legeay S Faure S Is bisphenol A an environmental obesogen? Fundam Clin Pharmacol 2017 31 6 594 609 10.1111/fcp.12300 28622415
Legeay S, Faure S. Is bisphenol A an environmental obesogen? Fundam Clin Pharmacol. 2017;31(6):594–609. 10.1111/fcp.12300.28622415 10.1111/fcp.12300
44. Liu G Dhana K Furtado JD Rood J Zong G Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: a prospective study PLoS Med 2018 15 2 e1002502 10.1371/journal.pmed.1002502 29438414
Liu G, Dhana K, Furtado JD, Rood J, Zong G, et al. Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: a prospective study. PLoS Med. 2018;15(2): e1002502. 10.1371/journal.pmed.1002502.29438414 10.1371/journal.pmed.1002502
45. Lustig RH Collier D Kassotis C Roepke TA Kim MJ Blanc E Barouki R Bansal A Cave MC Chatterjee S Choudhury M Gilbertson M Lagadic-Gossmann D Howard S Lind L Tomlinson CR Vondracek J Heindel JJ Obesity I: overview and molecular and biochemical mechanisms Biochem Pharmacol 2022 199 115012 10.1016/j.bcp.2022.115012 35393120
Lustig RH, Collier D, Kassotis C, Roepke TA, Kim MJ, Blanc E, Barouki R, Bansal A, Cave MC, Chatterjee S, Choudhury M, Gilbertson M, Lagadic-Gossmann D, Howard S, Lind L, Tomlinson CR, Vondracek J, Heindel JJ. Obesity I: overview and molecular and biochemical mechanisms. Biochem Pharmacol. 2022;199:115012. 10.1016/j.bcp.2022.115012.35393120 10.1016/j.bcp.2022.115012
46. Mahboobifard F Pourgholami MH Jorjani M Dargahi L Amiri M Estrogen as a key regulator of energy homeostasis and metabolic health Biomed Pharmacother 2022 156 113808 10.1016/j.biopha.2022.113808 36252357
Mahboobifard F, Pourgholami MH, Jorjani M, Dargahi L, Amiri M. Estrogen as a key regulator of energy homeostasis and metabolic health. Biomed Pharmacother. 2022;156: 113808. 10.1016/j.biopha.2022.113808.36252357 10.1016/j.biopha.2022.113808
47. Marotta V Grumetto L Neri I Russo G Tortora A Izzo G Panariello I Rocco D Pezzullo L Vitale M Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patients Environ Pollut 2023 316 Pt1 120478 10.1016/j.envpol.2022.120478 36306887
Marotta V, Grumetto L, Neri I, Russo G, Tortora A, Izzo G, Panariello I, Rocco D, Pezzullo L, Vitale M. Exposure to Bisphenol A increases malignancy risk of thyroid nodules in overweight/obese patients. Environ Pollut. 2023;316(Pt1):120478. 10.1016/j.envpol.2022.120478.36306887 10.1016/j.envpol.2022.120478
48. Maqbool F Mostafalou S Bahadar H Abdollahi M Review of endocrine disorders associated with environmental toxicants and possible involved mechanisms Life Sci 2016 15 145 265 273 10.1016/j.lfs.2015.10.022
Maqbool F, Mostafalou S, Bahadar H, Abdollahi M. Review of endocrine disorders associated with environmental toxicants and possible involved mechanisms. Life Sci. 2016;15(145):265–73. 10.1016/j.lfs.2015.10.022. (Epub 2015 Oct 21 PMID: 26497928).10.1016/j.lfs.2015.10.022
49. Mendes V, Ribeiro C, Delgado I, Peleteiro B, Aggerbeck M, et at. The association between environmental exposures to chlordanes, adiposity and diabetes-related features: a systematic review and meta-analysis. Sci Rep. 2021; 11(1):14546. 10.1038/s41598-021-93868-4
50. Menale C Piccolo MT Cirillo G Calogero RA Papparella A Bisphenol A effects on gene expression in adipocytes from children: association with metabolic disorders J Mol Endocrinol 2015 54 3 289 303 10.1530/JME-14-0282 25878060
Menale C, Piccolo MT, Cirillo G, Calogero RA, Papparella A. Bisphenol A effects on gene expression in adipocytes from children: association with metabolic disorders. J Mol Endocrinol. 2015;54(3):289–303. 10.1530/JME-14-0282.25878060 10.1530/JME-14-0282
51. Milankov A Milanović M Milošević N Sudji J Pejaković S Milić N Bjelica A Medić SM The effects of phthalate exposure on metabolic parameters in polycystic ovary syndrome Clin Chim Acta 2023 1 540 117225 10.1016/j.cca.2023.117225
Milankov A, Milanović M, Milošević N, Sudji J, Pejaković S, Milić N, Bjelica A, Medić SM. The effects of phthalate exposure on metabolic parameters in polycystic ovary syndrome. Clin Chim Acta. 2023;1(540):117225. 10.1016/j.cca.2023.117225.10.1016/j.cca.2023.117225
52. Milanović M Milošević N Milić N Stojanoska MM Petri E Filipović JM Food contaminants and potential risk of diabetes development: a narrative review World J Diabetes 2023 14 6 705 723 10.4239/wjd.v14.i6.705.PMID:37383596;PMCID:PMC10294057 37383596
Milanović M, Milošević N, Milić N, Stojanoska MM, Petri E, Filipović JM. Food contaminants and potential risk of diabetes development: a narrative review. World J Diabetes. 2023;14(6):705–23. 10.4239/wjd.v14.i6.705.PMID:37383596;PMCID:PMC10294057.37383596 10.4239/wjd.v14.i6.705.PMID:37383596;PMCID:PMC10294057
53. Milošević N Milanović M Sudji J Bosić Živanović D Stojanoski S Vuković B Milić N Medić SM Could phthalates exposure contribute to the development of metabolic syndrome and liver disease in humans? Environ Sci Pollut Res Int 2020 27 1 772 784 10.1007/s11356-019-06831-2 31808097
Milošević N, Milanović M, Sudji J, Bosić Živanović D, Stojanoski S, Vuković B, Milić N, Medić SM. Could phthalates exposure contribute to the development of metabolic syndrome and liver disease in humans? Environ Sci Pollut Res Int. 2020;27(1):772–84. 10.1007/s11356-019-06831-2. (Epub 2019 Dec 6 PMID: 31808097).31808097 10.1007/s11356-019-06831-2
54. Modica R Benevento E Colao A Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship J Endocrinol Invest 2023 46 4 667 677 10.1007/s40618-022-01983-4 36526827
Modica R, Benevento E, Colao A. Endocrine-disrupting chemicals (EDCs) and cancer: new perspectives on an old relationship. J Endocrinol Invest. 2023;46(4):667–77. 10.1007/s40618-022-01983-4. (Epub 2022 Dec 16 PMID: 36526827).36526827 10.1007/s40618-022-01983-4
55. Naomi R Yazid MD Bahari H Keong YY Rajandram R Bisphenol A (BPA) leading to obesity and cardiovascular complications: a compilation of current in vivo study Int J Mol Sci 2022 23 6 2969 10.3390/ijms23062969 35328389
Naomi R, Yazid MD, Bahari H, Keong YY, Rajandram R. Bisphenol A (BPA) leading to obesity and cardiovascular complications: a compilation of current in vivo study. Int J Mol Sci. 2022;23(6):2969. 10.3390/ijms23062969.35328389 10.3390/ijms23062969
56. Newbold RR Padilla-Banks E Snyder RJ Phillips TM Jefferson WN Developmental exposure to endocrine disruptors and the obesity epidemic Reprod Toxicol 2007 23 3 290 296 10.1016/j.reprotox.2006.12.010 17321108
Newbold RR, Padilla-Banks E, Snyder RJ, Phillips TM, Jefferson WN. Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod Toxicol. 2007;23(3):290–6. 10.1016/j.reprotox.2006.12.010.17321108 10.1016/j.reprotox.2006.12.010
57. Predieri B Bruzzi P Bigi E Ciancia S Madeo SF Endocrine disrupting chemicals and type 1 diabetes Int J Mol Sci 2020 21 8 2937 10.3390/ijms21082937 32331412
Predieri B, Bruzzi P, Bigi E, Ciancia S, Madeo SF, et al. Endocrine disrupting chemicals and type 1 diabetes. Int J Mol Sci. 2020;21(8):2937. 10.3390/ijms21082937.32331412 10.3390/ijms21082937
58. Ribeiro E Ladeira C Viegas S EDCs mixtures: a stealthy hazard for human health? Toxics 2017 5 1 5 10.3390/toxics5010005.PMID:29051438;PMCID:PMC5606671 29051438
Ribeiro E, Ladeira C, Viegas S. EDCs mixtures: a stealthy hazard for human health? Toxics. 2017;5(1):5. 10.3390/toxics5010005.PMID:29051438;PMCID:PMC5606671.29051438 10.3390/toxics5010005.PMID:29051438;PMCID:PMC5606671
59. Ribeiro CM Beserra BTS Silva NG Lima CL Rocha PRS Exposure to endocrine-disrupting chemicals and anthropometric measures of obesity: a systematic review and meta-analysis BMJ Open 2020 10 6 e033509 10.1136/bmjopen-2019-033509 32565448
Ribeiro CM, Beserra BTS, Silva NG, Lima CL, Rocha PRS, et al. Exposure to endocrine-disrupting chemicals and anthropometric measures of obesity: a systematic review and meta-analysis. BMJ Open. 2020;10(6): e033509. 10.1136/bmjopen-2019-033509.32565448 10.1136/bmjopen-2019-033509
60. Richter CA Birnbaum LS Farabollini F Newbold RR Rubin BS In vivo effects of bisphenol A in laboratory rodent studies Reprod Toxicol 2007 24 2 199 224 10.1016/j.reprotox.2007.06.004 17683900
Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, et al. In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol. 2007;24(2):199–224. 10.1016/j.reprotox.2007.06.004.17683900 10.1016/j.reprotox.2007.06.004
61. Runkel AA Mazej D Snoj Tratnik J Tkalec Ž Kosjek T Exposure of men and lactating women to environmental phenols, phthalates, and DINCH Chemosphere 2022 286 3 131858 10.1016/j.chemosphere.2021.131858 34399256
Runkel AA, Mazej D, Snoj Tratnik J, Tkalec Ž, Kosjek T, et al. Exposure of men and lactating women to environmental phenols, phthalates, and DINCH. Chemosphere. 2022;286(3): 131858. 10.1016/j.chemosphere.2021.131858.34399256 10.1016/j.chemosphere.2021.131858
62. Sanchis Y Coscollà C Yusà V Analysis of four parabens and bisphenols A, F, S in urine, using dilute and shoot and liquid chromatography coupled to mass spectrometry Talanta 2019 202 42 50 10.1016/j.talanta.2019.04.048 31171203
Sanchis Y, Coscollà C, Yusà V. Analysis of four parabens and bisphenols A, F, S in urine, using dilute and shoot and liquid chromatography coupled to mass spectrometry. Talanta. 2019;202:42–50. 10.1016/j.talanta.2019.04.048.31171203 10.1016/j.talanta.2019.04.048
63. Shankar A Teppala S Sabanayagam C Bisphenol A and peripheral arterial disease: results from the NHANES Environ Health Perspect 2012 120 9 1297 1300 10.1289/ehp.1104114 22645278
Shankar A, Teppala S, Sabanayagam C. Bisphenol A and peripheral arterial disease: results from the NHANES. Environ Health Perspect. 2012;120(9):1297–300. 10.1289/ehp.1104114.22645278 10.1289/ehp.1104114
64. Srnovršnik T Virant-Klun I Pinter B Polycystic ovary syndrome and endocrine disruptors (bisphenols, parabens, and triclosan)—a systematic review Life (Basel) 2023 13 1 138 10.3390/life13010138 36676087
Srnovršnik T, Virant-Klun I, Pinter B. Polycystic ovary syndrome and endocrine disruptors (bisphenols, parabens, and triclosan)—a systematic review. Life (Basel). 2023;13(1):138. 10.3390/life13010138.36676087 10.3390/life13010138
65. Tkalec Ž Kosjek T Snoj Tratnik J Stajnko A Runkel AA Exposure of Slovenian children and adolescents to bisphenols, parabens and triclosan: urinary levels, exposure patterns, determinants of exposure and susceptibility Environ Int 2021 146 106172 10.1016/j.envint.2020.106172 33113465
Tkalec Ž, Kosjek T, Snoj Tratnik J, Stajnko A, Runkel AA, et al. Exposure of Slovenian children and adolescents to bisphenols, parabens and triclosan: urinary levels, exposure patterns, determinants of exposure and susceptibility. Environ Int. 2021;146: 106172. 10.1016/j.envint.2020.106172.33113465 10.1016/j.envint.2020.106172
66. Thompson A Griffin P Stuetz R Cartmell E The fate and removal of triclosan during wastewater treatment Water Environ Res 2005 77 1 63 67 10.2175/106143005X41636 15765937
Thompson A, Griffin P, Stuetz R, Cartmell E. The fate and removal of triclosan during wastewater treatment. Water Environ Res. 2005;77(1):63–7. 10.2175/106143005X41636.15765937 10.2175/106143005X41636
67. Tricco AC Lillie E Zarin W O'Brien KK Colquhoun H Levac D Moher D Peters MDJ Horsley T Weeks L Hempel S Akl EA Chang C McGowan J Stewart L Hartling L Aldcroft A Wilson MG Garritty C Lewin S Godfrey CM Macdonald MT Langlois EV Soares-Weiser K Moriarty J Clifford T Tunçalp Ö Straus SE PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation Ann Intern Med 2018 169 7 467 473 10.7326/M18-0850 30178033
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73. 10.7326/M18-0850. (Epub 2018 Sep 4 PMID: 30178033).30178033 10.7326/M18-0850
68. Viñas R Watson CS Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions Environ Health Perspect 2013 121 3 352 358 10.1289/ehp.1205826 23458715
Viñas R, Watson CS. Bisphenol S disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Environ Health Perspect. 2013;121(3):352–8. 10.1289/ehp.1205826.23458715 10.1289/ehp.1205826
69. Wang Y Hollis-Hansen K Ren X Qiu Y Qu W Do environmental pollutants increase obesity risk in humans? Obes Rev 2016 17 12 1179 1197 10.1111/obr.12463 27706898
Wang Y, Hollis-Hansen K, Ren X, Qiu Y, Qu W. Do environmental pollutants increase obesity risk in humans? Obes Rev. 2016;17(12):1179–97. 10.1111/obr.12463. (Epub 2016 Oct 5 PMID: 27706898).27706898 10.1111/obr.12463
70. Wang Y Song J Wang X Qian Q Wang H Study on the toxic-mechanism of triclosan chronic exposure to zebrafish (Danio rerio) based on gut-brain axis Sci Total Environ 2022 2022844 156936 10.1016/j.scitotenv.2022.156936
Wang Y, Song J, Wang X, Qian Q, Wang H. Study on the toxic-mechanism of triclosan chronic exposure to zebrafish (Danio rerio) based on gut-brain axis. Sci Total Environ. 2022;2022844: 156936. 10.1016/j.scitotenv.2022.156936.10.1016/j.scitotenv.2022.156936
71. Wassenaar PNH Legler J Systematic review and meta-analysis of early life exposure to di(2-ethylhexyl) phthalate and obesity related outcomes in rodents Chemosphere 2017 188 174 181 10.1016/j.chemosphere.2017.08.165 28886551
Wassenaar PNH, Legler J. Systematic review and meta-analysis of early life exposure to di(2-ethylhexyl) phthalate and obesity related outcomes in rodents. Chemosphere. 2017;188:174–81. 10.1016/j.chemosphere.2017.08.165.28886551 10.1016/j.chemosphere.2017.08.165
72. Wetherill YB Akingbemi BT Kanno J McLachlan JA Nadal A In vitro molecular mechanisms of bisphenol A action Reprod Toxicol 2007 24 2 178 198 10.1016/j.reprotox.2007.05.010 17628395
Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, et al. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol. 2007;24(2):178–98. 10.1016/j.reprotox.2007.05.010.17628395 10.1016/j.reprotox.2007.05.010
73. Woodruff TJ Charlesworth A Zlatnik MG Pandipati S DeNicola N Code OB: we need urgent action on climate change and toxic chemicals Int J Gynaecol Obstet 2023 160 2 363 365 10.1002/ijgo.14566 36649076
Woodruff TJ, Charlesworth A, Zlatnik MG, Pandipati S, DeNicola N, et al. Code OB: we need urgent action on climate change and toxic chemicals. Int J Gynaecol Obstet. 2023;160(2):363–5. 10.1002/ijgo.14566.36649076 10.1002/ijgo.14566
74. WHO, 2021. Obesity and overweight. 2021–2023. World Health Organization; [Accessed 2023, Oct 2]. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight/.
75. Wu Q Li G Zhao CY Na XL Zhang YB Association between phthalate exposure and obesity risk: a meta-analysis of observational studies Environ Toxicol Pharmacol 2023 102 104240 10.1016/j.etap.2023.104240 37549759
Wu Q, Li G, Zhao CY, Na XL, Zhang YB. Association between phthalate exposure and obesity risk: a meta-analysis of observational studies. Environ Toxicol Pharmacol. 2023;102: 104240. 10.1016/j.etap.2023.104240. (Epub 2023 Aug 5 PMID: 37549759).37549759 10.1016/j.etap.2023.104240
